Xtant Current Deferred Revenue vs Total Assets Analysis

XTNT Stock  USD 0.40  0.01  2.44%   
Xtant Medical financial indicator trend analysis is more than just analyzing Xtant Medical Holdings current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Xtant Medical Holdings is a good investment. Please check the relationship between Xtant Medical Current Deferred Revenue and its Total Assets accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xtant Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Current Deferred Revenue vs Total Assets

Current Deferred Revenue vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Xtant Medical Holdings Current Deferred Revenue account and Total Assets. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Xtant Medical's Current Deferred Revenue and Total Assets is 0.83. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Total Assets in the same time period over historical financial statements of Xtant Medical Holdings, assuming nothing else is changed. The correlation between historical values of Xtant Medical's Current Deferred Revenue and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Xtant Medical Holdings are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Current Deferred Revenue i.e., Xtant Medical's Current Deferred Revenue and Total Assets go up and down completely randomly.

Correlation Coefficient

0.83
Relationship DirectionPositive 
Relationship StrengthStrong

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Total Assets

Total assets refers to the total amount of Xtant Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Xtant Medical Holdings books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Xtant Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Xtant Medical Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xtant Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Xtant Medical's Sales General And Administrative To Revenue is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 31.54 in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 9.6 M in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit32.5M32.1M55.5M34.0M
Total Revenue55.3M58.0M91.3M53.7M

Xtant Medical fundamental ratios Correlations

-0.080.830.00.76-0.160.920.090.090.760.090.640.280.150.820.760.780.960.830.940.17-0.240.750.480.150.91
-0.080.170.81-0.54-0.43-0.140.160.160.420.790.560.360.64-0.430.29-0.54-0.09-0.1-0.25-0.33-0.07-0.580.620.35-0.2
0.830.170.050.61-0.340.77-0.04-0.040.70.160.710.460.320.650.720.610.830.790.73-0.03-0.250.530.450.550.66
0.00.810.05-0.62-0.24-0.170.370.370.310.760.410.160.53-0.520.29-0.6-0.01-0.22-0.13-0.18-0.04-0.640.510.39-0.01
0.76-0.540.61-0.620.040.81-0.27-0.270.44-0.40.280.05-0.210.980.340.990.760.770.830.2-0.190.990.13-0.110.73
-0.16-0.43-0.34-0.240.04-0.05-0.57-0.57-0.46-0.72-0.63-0.68-0.95-0.05-0.65-0.02-0.2-0.350.130.620.650.05-0.42-0.390.18
0.92-0.140.77-0.170.81-0.05-0.07-0.070.72-0.030.590.190.020.870.640.820.890.770.880.26-0.150.810.47-0.030.82
0.090.16-0.040.37-0.27-0.57-0.071.00.090.550.150.420.6-0.160.5-0.160.040.11-0.14-0.25-0.33-0.170.010.05-0.15
0.090.16-0.040.37-0.27-0.57-0.071.00.090.550.150.420.6-0.160.5-0.160.040.11-0.14-0.25-0.33-0.170.010.05-0.15
0.760.420.70.310.44-0.460.720.090.090.550.940.310.530.560.770.450.790.610.61-0.16-0.30.410.890.180.6
0.090.790.160.76-0.4-0.72-0.030.550.550.550.680.490.88-0.260.56-0.340.110.1-0.16-0.56-0.44-0.390.720.29-0.14
0.640.560.710.410.28-0.630.590.150.150.940.680.480.710.410.780.30.670.590.45-0.25-0.390.240.90.320.43
0.280.360.460.160.05-0.680.190.420.420.310.490.480.640.130.60.090.160.590.06-0.27-0.490.060.250.24-0.04
0.150.640.320.53-0.21-0.950.020.60.60.530.880.710.64-0.10.66-0.160.190.25-0.14-0.59-0.58-0.230.560.44-0.15
0.82-0.430.65-0.520.98-0.050.87-0.16-0.160.56-0.260.410.13-0.10.440.990.810.830.860.2-0.220.980.25-0.120.76
0.760.290.720.290.34-0.650.640.50.50.770.560.780.60.660.440.40.750.670.49-0.19-0.40.350.580.290.46
0.78-0.540.61-0.60.99-0.020.82-0.16-0.160.45-0.340.30.09-0.160.990.40.780.80.830.17-0.240.990.12-0.10.74
0.96-0.090.83-0.010.76-0.20.890.040.040.790.110.670.160.190.810.750.780.750.90.08-0.250.730.530.250.87
0.83-0.10.79-0.220.77-0.350.770.110.110.610.10.590.590.250.830.670.80.750.76-0.04-0.350.760.340.110.62
0.94-0.250.73-0.130.830.130.88-0.14-0.140.61-0.160.450.06-0.140.860.490.830.90.760.32-0.120.810.350.060.97
0.17-0.33-0.03-0.180.20.620.26-0.25-0.25-0.16-0.56-0.25-0.27-0.590.2-0.190.170.08-0.040.320.590.25-0.25-0.410.36
-0.24-0.07-0.25-0.04-0.190.65-0.15-0.33-0.33-0.3-0.44-0.39-0.49-0.58-0.22-0.4-0.24-0.25-0.35-0.120.59-0.17-0.3-0.3-0.08
0.75-0.580.53-0.640.990.050.81-0.17-0.170.41-0.390.240.06-0.230.980.350.990.730.760.810.25-0.170.09-0.230.71
0.480.620.450.510.13-0.420.470.010.010.890.720.90.250.560.250.580.120.530.340.35-0.25-0.30.090.140.37
0.150.350.550.39-0.11-0.39-0.030.050.050.180.290.320.240.44-0.120.29-0.10.250.110.06-0.41-0.3-0.230.140.08
0.91-0.20.66-0.010.730.180.82-0.15-0.150.6-0.140.43-0.04-0.150.760.460.740.870.620.970.36-0.080.710.370.08
Click cells to compare fundamentals

Xtant Medical Account Relationship Matchups

Xtant Medical fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets43.2M41.5M54.7M60.2M92.6M60.0M
Other Current Liab7K5.7M3.9M5.0M9.5M10.0M
Total Current Liabilities9.4M25.6M11.1M15.2M23.0M16.0M
Total Stockholder Equity(44.2M)14.5M30.9M34.2M51.3M53.9M
Net Debt73.3M16.2M(1.4M)(3.2M)17.8M17.0M
Retained Earnings(223.3M)(230.3M)(235.2M)(243.7M)(243.0M)(230.9M)
Accounts Payable2.2M2.3M2.6M3.5M7.1M4.9M
Cash5.2M2.3M18.2M20.3M5.7M5.8M
Cash And Short Term Investments5.2M2.3M18.2M20.3M5.7M5.8M
Net Receivables10.1M6.9M7.2M10.9M20.7M21.8M
Common Stock Shares Outstanding13.2M28.5M85.5M94.1M126.8M133.1M
Liabilities And Stockholders Equity43.2M41.5M54.7M60.2M92.6M60.0M
Inventory16.1M21.4M17.9M17.3M36.9M38.7M
Other Current Assets784K1.5M988K1.6M1.5M830.2K
Other Stockholder Equity179.1M244.9M266.1M277.8M294.3M309.0M
Total Liab87.4M27.0M23.8M26.1M41.3M60.8M
Total Current Assets32.2M31.4M44.3M49.3M64.9M33.6M
Short Long Term Debt Total78.5M18.5M16.8M17.1M23.6M22.4M
Property Plant And Equipment Net6.8M6.0M6.5M7.2M10.2M7.8M
Non Current Assets Total10.9M10.1M10.4M10.9M27.7M28.2M
Non Currrent Assets Other394K402K287K197K141K134.0K
Non Current Liabilities Total78.0M1.3M12.7M10.8M18.3M17.4M
Property Plant And Equipment Gross6.8M4.3M6.5M7.2M29.9M31.4M
Short Term Debt570K17.7M4.6M6.8M6.4M3.9M
Intangible Assets515K457K400K344K10.1M7.8M
Other Assets394K2.1M287K197K1.00.95
Long Term Debt77.9M76.2M11.8M9.7M17.2M16.3M
Property Plant Equipment6.8M4.3M6.5M5.8M6.7M7.6M
Retained Earnings Total Equity(215.0M)(223.3M)(230.3M)(243.7M)(219.3M)(208.3M)
Net Tangible Assets(47.9M)10.9M27.3M30.6M35.2M37.0M
Long Term Debt Total138.6M78.1M76.2M9.7M8.7M8.3M
Capital Surpluse171.3M179.1M244.9M277.8M319.5M177.0M
Capital Lease Obligations2.3M1.7M1.4M1.7M1.8M1.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Xtant Stock Analysis

When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.